Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, pre ceding other skin and articular involvement. No pediat ric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child
Diluvio, L., Campione, E., Paternò, E., Mordenti, C., El Hachem, M., Chimenti, S. (2007). Childhood nail psoriasis: a useful treatment with tazarotene 0.05%. PEDIATRIC DERMATOLOGY, 24(3), 332-333 [10.1111/j.1525-1470.2007.00421.x].
Childhood nail psoriasis: a useful treatment with tazarotene 0.05%
Campione E;
2007-01-01
Abstract
Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, pre ceding other skin and articular involvement. No pediat ric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child| File | Dimensione | Formato | |
|---|---|---|---|
|
Sesto articolo Campione.pdf
accesso aperto
Descrizione: letter
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
621.23 kB
Formato
Adobe PDF
|
621.23 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
